ch.oddb.org
 
Apotheken | Doctor | Drugs | Hospital | Interactions | MiGeL | Registration owner | Services
Xolair 75 mg/0.5 ml, Injektionslösung in einem Fertigpen - 
69272001 Novartis Pharma Schweiz AG
Xolair 75 mg/0.5 ml, Injektionslösung in einem Fertigpen03.07.2024
  03.07.2024
Omalizumab (R03DX05) 
WHO-DDD02.07.2029
03.04.50. 
03.04.50. 
B  
No 
IPCI
PR  
k.A.PR
  
7680692720016Biotechnologika
  
Composition
omalizumabum 75 mg, arginini hydrochloridum, histidini hydrochloridum monohydricum, histidinum, polysorbatum 20, aqua ad iniectabile q.s. ad solutionem pro 0.5 ml.
Packungsbestandteile
 
 
 
Active AgentDose
Omalizumab75mg / 0.5ml
 
Inactive agents
Arginine Hydrochloride
Histidin Hydrochloride Monohydrate
Histidine
 
Source
Data was imported : 07.08.2024 Swissmedic Registration : Sequence : Product name : Registration owner: : Product group : Index Therapeuticus (BSV) : Medication Code : Date of registration : Valid until : Package number : Show package size : Commercial Form/Unit : Swissmedic categorie. : Active Agents : Composition :
 
2025 ©ywesee GmbH
Settings | Help | FAQ | Login | Contact | Home